Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heli Harvala

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Transfusion Medicine (Oxford, England)|September 5, 2023
Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEPVictoria Maddox, Pamela Vallely, Susan R Brailsford, et al.
Journal of Global Health|August 19, 2021
Mapping of serological testing and SARS-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020Laura Bubba, Peter Simmonds, Thea K Fischer, et al.
Reviews in Medical Virology|February 20, 2024
Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?Michael X Fu, Peter Simmonds, Monique Andersson, et al.
The Journal of General Virology|June 17, 2005
Tissue tropism of recombinant coxsackieviruses in an adult mouse modelHeli Harvala, Hannu Kalimo, Jeffrey Bergelson, et al.
Transfusion Medicine (Oxford, England)|June 25, 2022
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in EnglandSarah Williams, Jeremy Ratcliff, Dung Nguyen, et al.
Expert Review of Anti-Infective Therapy|December 8, 2010
The need for treatment against human parechoviruses: how, why and when?Joanne G Wildenbeest, Heli Harvala, Dasja Pajkrt, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 30, 2014
Acute viral hepatitis - should the current screening strategy be modified?Heli Harvala, Vincent Wong, Peter Simmonds, et al.
Transfusion Medicine (Oxford, England)|June 25, 2022
Blood donor notification of variant Creutzfeldt-Jakob disease risk: Lessons in communicating donor deferral and riskClaire A Reynolds, Tali Yawitch, Patricia E Hewitt, et al.
Transfusion Medicine (Oxford, England)|April 18, 2022
Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titresJennifer Mehew, Rachel Johnson, David Roberts, et al.
The Lancet. Infectious Diseases|October 17, 2018
Strategies to improve detection and management of human parechovirus infection in young infantsSeilesh Kadambari, Heli Harvala, Peter Simmonds, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Transfusion Medicine (Oxford, England)|September 5, 2023
Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEPVictoria Maddox, Pamela Vallely, Susan R Brailsford, et al.
Journal of Global Health|August 19, 2021
Mapping of serological testing and SARS-CoV-2 seroprevalence studies performed in 20 European countries, March-June 2020Laura Bubba, Peter Simmonds, Thea K Fischer, et al.
Reviews in Medical Virology|February 20, 2024
Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?Michael X Fu, Peter Simmonds, Monique Andersson, et al.
The Journal of General Virology|June 17, 2005
Tissue tropism of recombinant coxsackieviruses in an adult mouse modelHeli Harvala, Hannu Kalimo, Jeffrey Bergelson, et al.
Transfusion Medicine (Oxford, England)|June 25, 2022
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in EnglandSarah Williams, Jeremy Ratcliff, Dung Nguyen, et al.
Expert Review of Anti-Infective Therapy|December 8, 2010
The need for treatment against human parechoviruses: how, why and when?Joanne G Wildenbeest, Heli Harvala, Dasja Pajkrt, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 30, 2014
Acute viral hepatitis - should the current screening strategy be modified?Heli Harvala, Vincent Wong, Peter Simmonds, et al.
Transfusion Medicine (Oxford, England)|June 25, 2022
Blood donor notification of variant Creutzfeldt-Jakob disease risk: Lessons in communicating donor deferral and riskClaire A Reynolds, Tali Yawitch, Patricia E Hewitt, et al.
Transfusion Medicine (Oxford, England)|April 18, 2022
Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titresJennifer Mehew, Rachel Johnson, David Roberts, et al.
The Lancet. Infectious Diseases|October 17, 2018
Strategies to improve detection and management of human parechovirus infection in young infantsSeilesh Kadambari, Heli Harvala, Peter Simmonds, et al.
Pageof 12